In the context of CRC, deficiency in adenomatous polyposis coli (APC) results in TCF4/β-catenin-mediated upregulation of the TDO2-Kyn-AhR axis to increase glycolysis and drive anabolic cancer cell growth (69). The gene discussed is AHR; the disease is colorectal carcinoma.